Selvita S.A. (WSE:SLV)

Poland flag Poland · Delayed Price · Currency is PLN
43.10
0.00 (0.00%)
At close: Feb 27, 2026
-3.58%
Market Cap 791.12M
Revenue (ttm) 373.90M
Net Income (ttm) -2.89M
Shares Out 18.36M
EPS (ttm) -0.16
PE Ratio n/a
Forward PE 49.54
Dividend n/a
Ex-Dividend Date n/a
Volume 5,623
Average Volume 19,284
Open 43.60
Previous Close 43.10
Day's Range 42.80 - 43.60
52-Week Range 26.50 - 49.40
Beta -0.06
RSI 48.08
Earnings Date Mar 27, 2026

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Sector Healthcare
Founded 2007
Employees 969
Stock Exchange Warsaw Stock Exchange
Ticker Symbol SLV
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.